Alaunos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2003 | — | — | $0 |
| FY2008 | — | — | $11.4M |
| FY2009 | — | — | $48.8M |
| FY2010 | $31.0M | $61.5M | $60.4M |
| FY2011 | $36.5M | $108.1M | $104.7M |
| FY2012 | $35.0M | $83.4M | $73.3M |
| FY2013 | $22.4M | $71.8M | $68.2M |
| FY2014 | $11.4M | $45.2M | $42.8M |
| FY2015 | $66.4M | $153.7M | $140.7M |
| FY2016 | $58.3M | $106.3M | $81.1M |
| FY2017 | $58.4M | $105.6M | $70.9M |
| FY2018 | $9.5M | $95.1M | $61.7M |
| FY2019 | $14.1M | $109.1M | $79.7M |
| FY2020 | $22.4M | $146.3M | $115.1M |
| FY2021 | $36.8M | $94.9M | $76.1M |
| FY2022 | $26.4M | $64.9M | $39.1M |
| FY2023 | $2.0M | $8.3M | $6.1M |
| FY2024 | $692.0K | $2.8M | $1.1M |
| FY2025 | $813.0K | $3.0M | $1.4M |